.jpg)
Novo’s Wegovy, J&J’s Tremfya step up TV ad spending amid March Madness tournament
Last year, AbbVie’s Skyrizi and Rinvoq were practically unshakeable atop the monthly TV drug ad spending rankings, ultimately leading the pair of immunology meds to take the full-year title for the third year in a row. 2025, however, is already off to a very different start.
Last year, AbbVie’s Skyrizi and Rinvoq were practically unshakeable atop the monthly TV drug ad spending rankings, ultimately leading the pair of immunology meds to take the full-year title for the third year in a row. 2025, however, is already off to a very different start.
